Evidence map›Paper›PMID 33799673›Full record

ReviewLife (Basel, Switzerland)2021

Arthritogenic

Shambhavi Rao, Adam Taylor

Open access · goldAbstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Getah Virus in Review: An Emerging Zoonotic Arbovirus.Transboundary and emerging diseases · 2026
    Review
  5. New Advances in Small Molecules Targeted at Viral Capsid-Genome Binding.International journal of molecular sciences · 2025
    Review
  6. Review
  7. Research trends on alphavirus receptors: a bibliometric analysis.Frontiers in cellular and infection microbiology · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Alphavirus Virulence Determinants.Pathogens (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Shambhavi RaoEmerging Viruses, Inflammation and Therapeutics Research Group, Gold Coast Campus, Menzies Health Institute Queensland Griffith University, Southport, QLD 4222, Australia.
Adam TaylorEmerging Viruses, Inflammation and Therapeutics Research Group, Gold Coast Campus, Menzies Health Institute Queensland Griffith University, Southport, QLD 4222, Australia.
Griffith University · AU

Funding

National Health and Medical Research Council of Australian 1122897
6 · The paper itself

Abstract

In the past two decades Old World and arthritogenic alphavirus have been responsible for epidemics of polyarthritis, causing high morbidity and becoming a major public health concern. The multifunctional arthritogenic alphavirus capsid protein is crucial for viral infection. Capsid protein has roles in genome encapsulation, budding and virion assembly. Its role in multiple infection processes makes capsid protein an attractive target to exploit in combating alphaviral infection. In this review, we summarize the function of arthritogenic alphavirus capsid protein, and describe studies that have used capsid protein to develop novel arthritogenic alphavirus therapeutic and diagnostic strategies.

Indexed as

antiviralscapsidold world alphavirusesvaccines

Identifiers

PMID33799673
PMCPMC7999773
OpenAlexW3135849122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.